MANKINDPharmaceuticals
Mankind Pharma Ltd — Balance Sheet
₹2005.80
+0.73%
Mankind Pharma Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Capitalization | 19.86K Cr | 9.39K Cr | 7.46K Cr | 6.20K Cr | — |
| Total Equity Gross Minority Interest | 14.57K Cr | 9.58K Cr | 7.62K Cr | 6.32K Cr | — |
| Minority Interest | 235.79 Cr | 212.70 Cr | 188.07 Cr | 161.08 Cr | — |
| Stockholders Equity | 14.33K Cr | 9.36K Cr | 7.44K Cr | 6.16K Cr | — |
| Other Equity Interest | 43.67 Cr | 23.25 Cr | 0.06 Cr | — | — |
| Retained Earnings | 11.91K Cr | 9.92K Cr | 8.01K Cr | 6.74K Cr | — |
| Additional Paid In Capital | 3.01K Cr | 42.12 Cr | 42.12 Cr | 42.12 Cr | — |
| Capital Stock | 41.26 Cr | 40.06 Cr | 40.06 Cr | 40.06 Cr | — |
| Common Stock | 41.26 Cr | 40.06 Cr | 40.06 Cr | 40.06 Cr | — |
| Total Liabilities Net Minority Interest | 13.19K Cr | 2.39K Cr | 2.09K Cr | 2.83K Cr | — |
| Total Non Current Liabilities Net Minority Interest | 7.53K Cr | 267.73 Cr | 229.02 Cr | 207.96 Cr | — |
| Other Non Current Liabilities | 20.00 Cr | 22.96 Cr | — | — | — |
| Non Current Pension And Other Postretirement Benefit Plans | 155.06 Cr | 123.12 Cr | 97.89 Cr | 80.00 Cr | — |
| Non Current Deferred Revenue | 20.00 Cr | 22.96 Cr | 25.49 Cr | 20.15 Cr | — |
| Non Current Deferred Taxes Liabilities | 1.81K Cr | 89.07 Cr | 77.31 Cr | 55.62 Cr | — |
| Long Term Debt And Capital Lease Obligation | 5.54K Cr | 32.58 Cr | 28.32 Cr | 52.18 Cr | — |
| Long Term Capital Lease Obligation | 14.03 Cr | 7.71 Cr | 5.18 Cr | 2.99 Cr | — |
| Long Term Debt | 5.53K Cr | 24.87 Cr | 23.15 Cr | 49.19 Cr | — |
| Long Term Provisions | 155.06 Cr | 123.12 Cr | — | — | — |
| Current Liabilities | 5.66K Cr | 2.12K Cr | 1.86K Cr | 2.62K Cr | — |
| Other Current Liabilities | 168.79 Cr | 120.73 Cr | 93.25 Cr | 205.74 Cr | — |
| Current Debt And Capital Lease Obligation | 2.97K Cr | 174.59 Cr | 142.05 Cr | 820.89 Cr | — |
| Current Capital Lease Obligation | 14.39 Cr | 3.42 Cr | 2.56 Cr | 2.06 Cr | — |
| Current Debt | 2.96K Cr | 171.17 Cr | 139.49 Cr | 818.83 Cr | — |
| Current Provisions | 663.87 Cr | 427.31 Cr | 307.63 Cr | 264.50 Cr | — |
| Payables | 1.67K Cr | 1.21K Cr | 1.16K Cr | 1.19K Cr | — |
| Other Payable | 514.93 Cr | 426.58 Cr | 100.98 Cr | 102.15 Cr | — |
| Total Tax Payable | 18.08 Cr | 8.38 Cr | 46.26 Cr | 15.09 Cr | — |
| Accounts Payable | 1.13K Cr | 777.06 Cr | 1.01K Cr | 1.08K Cr | — |
| Total Assets | 27.76K Cr | 11.96K Cr | 9.72K Cr | 9.15K Cr | — |
| Total Non Current Assets | 20.77K Cr | 5.40K Cr | 5.39K Cr | 4.74K Cr | — |
| Other Non Current Assets | 92.26 Cr | 66.28 Cr | — | — | — |
| Non Current Prepaid Assets | 72.97 Cr | 51.98 Cr | 28.60 Cr | 27.98 Cr | — |
| Non Current Deferred Taxes Assets | 107.89 Cr | 80.39 Cr | 29.78 Cr | 39.29 Cr | — |
| Investmentin Financial Assets | 293.91 Cr | 121.79 Cr | 176.35 Cr | 72.65 Cr | — |
| Available For Sale Securities | 264.99 Cr | 94.77 Cr | 147.50 Cr | 45.64 Cr | — |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | 28.92 Cr | 27.02 Cr | 28.84 Cr | 27.01 Cr | — |
| Long Term Equity Investment | 190.90 Cr | 189.28 Cr | 181.41 Cr | 167.74 Cr | — |
| Investmentsin Joint Venturesat Cost | 76.28 Cr | 77.58 Cr | 77.88 Cr | 63.92 Cr | — |
| Investmentsin Associatesat Cost | 114.62 Cr | 111.70 Cr | 103.54 Cr | 103.82 Cr | — |
| Investment Properties | 0.05 Cr | 5.32 Cr | 5.37 Cr | 5.42 Cr | — |
| Goodwill And Other Intangible Assets | 16.62K Cr | 1.68K Cr | 1.78K Cr | 1.89K Cr | — |
| Other Intangible Assets | 10.12K Cr | 1.66K Cr | 1.76K Cr | 1.87K Cr | — |
| Goodwill | 6.49K Cr | 20.02 Cr | 20.02 Cr | 20.44 Cr | — |
| Net PPE | 3.26K Cr | 3.17K Cr | 3.08K Cr | 2.45K Cr | — |
| Accumulated Depreciation | -1.16K Cr | -963.39 Cr | -743.73 Cr | -582.24 Cr | — |
| Gross PPE | 4.42K Cr | 4.13K Cr | 3.82K Cr | 3.03K Cr | — |
| Construction In Progress | 351.35 Cr | 239.36 Cr | 552.00 Cr | 728.52 Cr | — |
| Other Properties | 2.91K Cr | 2.93K Cr | — | — | — |
| Machinery Furniture Equipment | 2.46K Cr | 2.15K Cr | 1.74K Cr | 1.39K Cr | — |
| Buildings And Improvements | 1.09K Cr | 1.28K Cr | 1.07K Cr | 601.42 Cr | — |
| Land And Improvements | 524.53 Cr | 465.38 Cr | 463.33 Cr | 308.43 Cr | — |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Current Assets | 6.99K Cr | 6.57K Cr | 4.33K Cr | 4.41K Cr | — |
| Other Current Assets | 802.82 Cr | 691.68 Cr | — | — | — |
| Assets Held For Sale Current | 2.70 Cr | 2.70 Cr | 3.32 Cr | 2.98 Cr | — |
| Restricted Cash | 51.35 Cr | 77.20 Cr | 15.41 Cr | 8.39 Cr | — |
| Prepaid Assets | 1.06K Cr | 1.08K Cr | 683.27 Cr | 931.81 Cr | — |
| Inventory | 2.09K Cr | 1.55K Cr | 1.50K Cr | 1.76K Cr | — |
| Finished Goods | 1.31K Cr | 1.00K Cr | 919.76 Cr | 1.20K Cr | — |
| Work In Process | 186.08 Cr | 99.79 Cr | 86.04 Cr | 94.04 Cr | — |
| Raw Materials | 597.33 Cr | 452.98 Cr | 451.65 Cr | 423.45 Cr | — |
| Other Receivables | 11.59 Cr | 39.40 Cr | 29.39 Cr | 35.92 Cr | — |
| Accounts Receivable | 1.54K Cr | 848.28 Cr | 576.42 Cr | 388.17 Cr | — |
| Allowance For Doubtful Accounts Receivable | -60.71 Cr | -28.25 Cr | -20.24 Cr | -11.09 Cr | — |
| Gross Accounts Receivable | 1.60K Cr | 876.53 Cr | 596.67 Cr | 399.26 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 2.23K Cr | 2.97K Cr | 1.52K Cr | 1.28K Cr | — |
| Other Short Term Investments | 1.83K Cr | 2.58K Cr | 1.22K Cr | 976.77 Cr | — |
| Cash And Cash Equivalents | 407.36 Cr | 382.01 Cr | 304.82 Cr | 302.53 Cr | — |
| Cash Equivalents | 150.58 Cr | 118.96 Cr | 7.01 Cr | — | — |
| Cash Financial | 256.78 Cr | 263.05 Cr | 297.81 Cr | 302.53 Cr | — |
| Ordinary Shares Number | 41.26 Cr | 40.06 Cr | 40.06 Cr | 40.06 Cr | — |
| Share Issued | 41.26 Cr | 40.06 Cr | 40.06 Cr | 40.06 Cr | — |
| Net Debt | 8.08K Cr | — | — | 565.49 Cr | 67.34 Cr |
| Total Debt | 8.51K Cr | 207.17 Cr | 170.37 Cr | 873.08 Cr | — |
| Tangible Book Value | -2.28K Cr | 7.68K Cr | 5.66K Cr | 4.26K Cr | — |
| Invested Capital | 22.82K Cr | 9.56K Cr | 7.60K Cr | 7.02K Cr | — |
| Working Capital | 1.32K Cr | 4.45K Cr | 2.46K Cr | 1.78K Cr | — |
| Net Tangible Assets | -2.28K Cr | 7.68K Cr | 5.66K Cr | 4.26K Cr | — |
| Capital Lease Obligations | 28.42 Cr | 11.13 Cr | 7.73 Cr | 5.05 Cr | — |
| Common Stock Equity | 14.33K Cr | 9.36K Cr | 7.44K Cr | 6.16K Cr | — |
| Treasury Shares Number | — | 0.00 | — | — | — |
| Other Inventories | — | — | 41.01 Cr | 42.56 Cr | 42.56 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Mankind Pharma Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.